Clinical

Dataset Information

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer


ABSTRACT: The primary objective of this study is to assess the safety and tolerability of KRN330 in patients with relapsed or refractory advanced or metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2047668 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR